These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 26318247)

  • 21. Development and characterization of a panel of cross-reactive monoclonal antibodies generated using H1N1 influenza virus.
    Guo CY; Tang YG; Qi ZL; Liu Y; Zhao XR; Huo XP; Li Y; Feng Q; Zhao PH; Wang X; Li Y; Wang HF; Hu J; Zhang XJ
    Immunobiology; 2015 Aug; 220(8):941-6. PubMed ID: 25708705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies.
    Kaverin NV; Rudneva IA; Govorkova EA; Timofeeva TA; Shilov AA; Kochergin-Nikitsky KS; Krylov PS; Webster RG
    J Virol; 2007 Dec; 81(23):12911-7. PubMed ID: 17881439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 Viruses.
    Tewawong N; Prachayangprecha S; Vichiwattana P; Korkong S; Klinfueng S; Vongpunsawad S; Thongmee T; Theamboonlers A; Poovorawan Y
    PLoS One; 2015; 10(10):e0139958. PubMed ID: 26440103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.
    Throsby M; van den Brink E; Jongeneelen M; Poon LL; Alard P; Cornelissen L; Bakker A; Cox F; van Deventer E; Guan Y; Cinatl J; ter Meulen J; Lasters I; Carsetti R; Peiris M; de Kruif J; Goudsmit J
    PLoS One; 2008; 3(12):e3942. PubMed ID: 19079604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice.
    O'Donnell CD; Vogel L; Wright A; Das SR; Wrammert J; Li GM; McCausland M; Zheng NY; Yewdell JW; Ahmed R; Wilson PC; Subbarao K
    mBio; 2012; 3(3):. PubMed ID: 22647789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in Mice.
    van der Lubbe JEM; Verspuij JWA; Huizingh J; Schmit-Tillemans SPR; Tolboom JTBM; Dekking LEHA; Kwaks T; Brandenburg B; Meijberg W; Zahn RC; Roozendaal R; Kuipers H
    Front Immunol; 2018; 9():2350. PubMed ID: 30369928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
    Yoshida R; Igarashi M; Ozaki H; Kishida N; Tomabechi D; Kida H; Ito K; Takada A
    PLoS Pathog; 2009 Mar; 5(3):e1000350. PubMed ID: 19300497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo evidence of a potential A(H1N1)pdm09 antigenic drift mediated by escape mutations in the haemagglutinin Sa antigenic site.
    Retamal M; Abed Y; Rhéaume C; Baz M; Boivin G
    J Gen Virol; 2017 Jun; 98(6):1224-1231. PubMed ID: 28631598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune history shapes specificity of pandemic H1N1 influenza antibody responses.
    Li Y; Myers JL; Bostick DL; Sullivan CB; Madara J; Linderman SL; Liu Q; Carter DM; Wrammert J; Esposito S; Principi N; Plotkin JB; Ross TM; Ahmed R; Wilson PC; Hensley SE
    J Exp Med; 2013 Jul; 210(8):1493-500. PubMed ID: 23857983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oligomerization of bacterially expressed H1N1 recombinant hemagglutinin contributes to protection against viral challenge.
    Kuenstling TE; Sambol AR; Hinrichs SH; Larson MA
    Sci Rep; 2018 Aug; 8(1):11856. PubMed ID: 30087372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of the amino acid differences between the hemagglutinin HA1 domains of influenza virus H1N1 strains on their reaction with antibody.
    Drescher J; Aron R
    J Med Virol; 1999 Apr; 57(4):397-404. PubMed ID: 10089053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic and antigenic characterization of influenza A(H1N1)pdm09 in Yantai, China, during the 2009-2017 influenza season.
    Liu J; Gong LF; Xu YC; Sun ZL; Gao Q; Dong ZJ
    J Med Virol; 2019 Mar; 91(3):351-360. PubMed ID: 30267587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.
    Wang X; Ilyushina NA; Lugovtsev VY; Bovin NV; Couzens LK; Gao J; Donnelly RP; Eichelberger MC; Wan H
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of common epitopes on hemagglutinin of the influenza A virus (H1 subtype).
    Guo C; Xie X; Li H; Zhao P; Zhao X; Sun J; Wang H; Liu Y; Li Y; Hu Q; Hu J; Li Y
    Exp Mol Pathol; 2015 Feb; 98(1):79-84. PubMed ID: 25533547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic sites of H1N1 influenza virus hemagglutinin revealed by natural isolates and inhibition assays.
    Huang JW; Lin WF; Yang JM
    Vaccine; 2012 Sep; 30(44):6327-37. PubMed ID: 22885274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variation in response among individuals to antigenic sites on the HA protein of human influenza virus may be responsible for the emergence of drift strains in the human population.
    Nakajima S; Nobusawa E; Nakajima K
    Virology; 2000 Aug; 274(1):220-31. PubMed ID: 10936103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diversifying Selection Analysis Predicts Antigenic Evolution of 2009 Pandemic H1N1 Influenza A Virus in Humans.
    Lee AJ; Das SR; Wang W; Fitzgerald T; Pickett BE; Aevermann BD; Topham DJ; Falsey AR; Scheuermann RH
    J Virol; 2015 May; 89(10):5427-40. PubMed ID: 25741011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-clade antibody reactivity may attenuate the ability of influenza virus to evade the immune response.
    Vashisht S; Verma S; Salunke DM
    Mol Immunol; 2019 Oct; 114():149-161. PubMed ID: 31352231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity.
    Kirkpatrick E; Henry C; McMahon M; Jiang K; Strohmeier S; van Bakel H; Wilson PC; Krammer F
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.